Results 131 to 140 of about 33,699 (271)

Assessment of drug permeability using a small airway microphysiological system

Frontiers in Pharmacology
BackgroundThere is a need to reliably predict the permeability of inhaled compounds during the development of new and generic drugs. A small airway microphysiological system (MPS) that can recapitulate the pulmonary air-liquid interface (ALI) with ...
Robert M. Geiger, Shekh M. Rahman, Md Shadiqur Rashid Roni, Catherine Sullenberger, Sabyasachy Mistry, Katherine Shea, Isra Tariq, Omnia A. Ismaiel, Murali K. Matta, Paula L. Hyland, Sasha Berdichevski, Sasha Berdichevski, Alexandre J. S. Ribeiro, Ksenia Blinova, Wenlei Jiang, Ross L. Walenga, Bryan Newman, Donna A. Volpe, Kevin A. Ford   +18 more
doaj   +1 more source

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax compared with Turbuhaler in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain [PDF]

, 2017
The objective of this study was to estimate the economic impact of the introduction of DuoResp® Spiromax®, budesonide/formoterol fixed-dose combination (FDC), focusing on an increase in medication adherence due to an enhancement of the inhalation ...
Bijedic, Adi, Darbà, Josep, García-Rivero, Juan L., Mayoralas, Sagrario, Pascual, José Francisco, Ramírez, Gabriela, Vargas, Diego   +6 more
core   +1 more source

Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial

, 2021
Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson, Jadwiga A. Wedzicha, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius, Paul Dorinsky   +8 more
openalex   +1 more source

Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry:A Cross-sectional Study of Common Conditions in the United States [PDF]

, 2013
BACKGROUND: Financial ties between health professionals and industry may unduly influence professional judgments and some researchers have suggested that widening disease definitions may be one driver of over-diagnosis, bringing potentially unnecessary ...
Bero, Lisa, Cooke, Georga P E, Doust, Jenny A., Glasziou, Paul P., Hill, Suzanne, Moynihan, Raymond N.   +5 more
core   +4 more sources

Polymorphism of spironolactone: An unprecedented case of monotropy turning to enantiotropy with a huge difference in the melting temperatures [PDF]

, 2018
Postprint (author's final ...
Barrio Casado, María del, Céolin, René, Lloveras Muntané, Pol Marcel, Rietveld, Ivo B., Tamarit Mur, José Luis   +4 more
core   +4 more sources

Corrigendum

International Journal of COPD, 2012
Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Banerjee S, Staudinger H. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52 ...
Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Banerjee S, Staudinger H   +7 more
doaj  

Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore

ClinicoEconomics and Outcomes Research, 2020
Sebastien Boisseau,1 Murtaza Qasuri,1 Weng Tong Ho,1 Wrik Ghosh,2 Yacine Hadjiat1 1Mundipharma Singapore Holding Pte Limited, Singapore; 2Costello Medical Singapore Pte Ltd, SingaporeCorrespondence: Yacine HadjiatMundipharma Singapore Holding Pte Limited,
Boisseau S, Qasuri M, Ho WT, Ghosh W, Hadjiat Y   +4 more
doaj  

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD

Respiratory Research, 2018
Background Long-acting muscarinic antagonist (LAMA) and long-acting β2-agonist (LABA) bronchodilators are key to the pharmacologic treatment of chronic obstructive pulmonary disease (COPD).
Edward M. Kerwin, Selwyn Spangenthal, Christine Kollar, Earl St Rose, Colin Reisner   +4 more
doaj   +1 more source

Kajian Pustaka Efektivitas dan Efek Samping Terapi Kombinasi Budesonide - Formoterol Fumarate pada Pasien Asma

, 2023
Riri Nur Oqviani, Elisabeth Kasih, Yufita Ratnasari Wilianto, Universitas Katolik Widya Mandala Surabaya, Yufita Ratnasari Wilianto, Universitas Katolik Widya Mandala Surabaya   +5 more
openalex   +2 more sources

EE602 Budget Impact Analysis of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate for COPD in the Italian Healthcare System [PDF]

, 2022
Danny Gibson, Cecilia Saleri, E de Nigris, Ulf Holmgren, Alberto Papi   +4 more
openalex   +1 more source